1. |
Astedt B, Holmberg L. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture [J]. Nature, 1976; 261(5561)∶595.
|
2. |
Chambers SK, Gertz RE Jr, Ivins CM, et al. The significance of urokinasetype plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer [J]. Cancer, 1995; 75(7)∶1627.
|
3. |
Konecny G, Untch M, Arboleda J, et al. Her2/neu and urokinasetype plasminogen activator and its inhibitor in breast cancer [J]. Clin Cancer Res, 2001; 7(8)∶2448.
|
4. |
Ito H, Yonemura Y, Fujita H, et al. Prognostic relevance of urokinasetype plasminogen activator (uPA) and plasminogen activator inhibitors PAI1 and PAI2 in gastric cancer [J]. Virchows Arch, 1996; 427(5)∶487.
|
5. |
Heiss MM, Babic R, Allgayer H, et al. Tumorassociated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinasetype plasminogen activator system [J]. J Clin Oncol, 1995; 13(8)∶2084.
|
6. |
Hsu DW, Efird JT, HedleyWhyte ET. Prognostic role of urokinasetype plasminogen activator in human gliomas [J]. Am J Pathol, 1995; 147(1)∶114.
|
7. |
Duggan C, Maguire T, McDermott E, et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer [J]. Int J Cancer, 1995; 61(5)∶597.
|
8. |
Schneider J, Pollan M, Tejerina A, et al. Accumulation of uPAPAI1 complexes inside the tumour cells is associated with axillary nodal invasion in progesteronereceptorpositive early breast cancer [J]. Br J Cancer, 2003; 88(1)∶96.
|
9. |
Spyratos F, Bouchet C, Tozlu S, et al. Prognostic value of uPA, PAI1 and PAI2 mRNA expression in primary breast cancer [J]. Anticancer Res, 2002; 22(5)∶2997.
|
10. |
Casella R, Shariat SF, Monoski MA, et al. Urinary levels of urokinasetype plasminogen activator and its receptor in the detection of bladder carcinoma [J]. Cancer, 2002; 95(12)∶2494.
|
11. |
Tanaka N, Fukao H, Ueshima S, et al. Plasminogen activator inhibitor 1 in human carcinoma tissues [J]. Int J Cancer, 1991; 48(4)∶481.
|
12. |
Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR [J]. Genome Res, 1996; 6(10)∶986.
|
13. |
Swan DC, Tucker RA, Holloway BP, et al. A sensitive, typespecific, fluorogenic probe assay for detection of human papillomavirus DNA [J]. J Clin Microbiol, 1997; 35(4)∶886.
|